Dita Ulase
Kiel, SH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.
Journal: The journal of pathology. Clinical research
Published: December 14, 2025
Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-world.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: February 10, 2025
Stroma AReactive Invasion Front Areas (SARIFA) predict poor survival in adenocarcinomas of the stomach and gastrooesophageal junction: a validation study.
Journal: Virchows Archiv : an international journal of pathology
Published: April 02, 2024
LAG3 in gastric cancer: it's complicated.
Journal: Journal of cancer research and clinical oncology
Published: April 10, 2023
Gastric Carcinomas with Stromal B7-H3 Expression Have Lower Intratumoural CD8+ T Cell Density.
Journal: International journal of molecular sciences
Published: January 22, 2021
Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
Journal: Histopathology
Published: July 10, 2019
The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: December 22, 2018
Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus.
Journal: Journal of cancer research and clinical oncology
Published: June 07, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026